• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉穿孔的临床特征和处理:单中心 11 年经验及实用综述。

Clinical Characteristics and Management of Coronary Artery Perforations: A Single-Center 11-Year Experience and Practical Overview.

机构信息

Thoraxcenter, Erasmus Medical Center, Rotterdam, Netherlands.

Thoraxcenter, Erasmus Medical Center, Rotterdam, Netherlands

出版信息

J Am Heart Assoc. 2017 Sep 22;6(9):e007049. doi: 10.1161/JAHA.117.007049.

DOI:10.1161/JAHA.117.007049
PMID:28939719
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5634316/
Abstract

BACKGROUND

Coronary artery perforation (CAP) is a potentially lethal complication of percutaneous coronary intervention. We report on the incidence, clinical characteristics, and management of iatrogenic coronary perforations based on an 11-year single-center experience.

METHODS AND RESULTS

From February 9, 2005, through November 20, 2016, 150 CAP cases were identified from our percutaneous coronary intervention database of 21 212 procedures (0.71%). Mean age of CAP patients was 66±11 years, and 62.7% were male. Treated lesion type was B2/C in 94.6%, and 31.3% were chronic total occlusions. Nonworkhorse guidewires were applied in 74.3%. CAP types were Ellis type I in 2.9%, Ellis type II in 40.4%, Ellis type III in 54.8%, and Ellis type III cavity spilling in 1.9%. CAP treatment was conservative (including prolonged balloon inflation) in 73.3%. Covered stents, coiling, and fat embolization were used in 24.0%, 0.7%, and 2.0%, respectively. Pericardiocentesis for tamponade was required for 72 patients (48.0%), of whom 28 were initially unrecognized. Twelve patients (12.7%) required emergency cardiac surgery to alleviate tamponade. Periprocedural myocardial infarction occurred in 34.0%, and in-hospital all-cause mortality was 8.0%. All-cause mortality accrued to 10.7% at 30 days and 17.8% at 1 year.

CONCLUSIONS

CAP is a rare complication of percutaneous coronary intervention, but morbidity and mortality are considerable. Early recognition and adequate management are of paramount importance.

摘要

背景

冠状动脉穿孔(CAP)是经皮冠状动脉介入治疗的一种潜在致命并发症。我们报告了基于 11 年单中心经验的医源性冠状动脉穿孔的发生率、临床特征和处理方法。

方法和结果

从 2005 年 2 月 9 日至 2016 年 11 月 20 日,我们从 21212 例经皮冠状动脉介入治疗的数据库中确定了 150 例 CAP 病例(0.71%)。CAP 患者的平均年龄为 66±11 岁,62.7%为男性。治疗病变类型为 B2/C 型占 94.6%,31.3%为慢性完全闭塞。74.3%应用非主力导丝。CAP 类型为 Ellis Ⅰ型占 2.9%,Ellis Ⅱ型占 40.4%,Ellis Ⅲ型占 54.8%,Ellis Ⅲ型腔外溢占 1.9%。73.3%的 CAP 患者采用保守治疗(包括长时间球囊扩张)。24.0%的患者采用覆盖支架、线圈和脂肪栓塞治疗,分别为 0.7%和 2.0%。72 例(48.0%)患者因心包填塞需要心包穿刺,其中 28 例最初未被发现。12 例(12.7%)患者需要紧急心脏手术以缓解填塞。围手术期心肌梗死发生率为 34.0%,住院期间全因死亡率为 8.0%。30 天和 1 年的全因死亡率分别为 10.7%和 17.8%。

结论

CAP 是经皮冠状动脉介入治疗的一种罕见并发症,但发病率和死亡率相当高。早期识别和充分处理至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f33e/5634316/621073675fee/JAH3-6-e007049-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f33e/5634316/6a0d19a68e53/JAH3-6-e007049-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f33e/5634316/621073675fee/JAH3-6-e007049-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f33e/5634316/6a0d19a68e53/JAH3-6-e007049-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f33e/5634316/621073675fee/JAH3-6-e007049-g002.jpg

相似文献

1
Clinical Characteristics and Management of Coronary Artery Perforations: A Single-Center 11-Year Experience and Practical Overview.冠状动脉穿孔的临床特征和处理:单中心 11 年经验及实用综述。
J Am Heart Assoc. 2017 Sep 22;6(9):e007049. doi: 10.1161/JAHA.117.007049.
2
Incidence, predictors, management and outcomes of coronary perforations.冠状动脉穿孔的发生率、预测因素、处理和结局。
Catheter Cardiovasc Interv. 2019 Jan 1;93(1):48-56. doi: 10.1002/ccd.27706. Epub 2018 Oct 12.
3
Predictors, treatment, and long-term outcomes of coronary perforation during retrograde percutaneous coronary intervention via epicardial collaterals for recanalization of chronic coronary total occlusion.经心外膜侧支逆行经皮冠状动脉介入治疗慢性完全闭塞性冠状动脉病变中冠状动脉穿孔的预测因素、治疗方法和长期转归。
Catheter Cardiovasc Interv. 2019 Feb 15;93(S1):800-809. doi: 10.1002/ccd.28093. Epub 2019 Jan 28.
4
"Incidence, clinical and angiographic characteristics, management and outcomes of coronary artery perforation at a high volume cardiac care center during percutaneous coronary intervention"."在高容量心脏护理中心进行经皮冠状动脉介入治疗期间冠状动脉穿孔的发生率、临床和血管造影特征、处理和结局"。
Indian Heart J. 2020 Jul-Aug;72(4):232-238. doi: 10.1016/j.ihj.2020.07.012. Epub 2020 Jul 17.
5
Coronary artery perforation complicating percutaneous coronary intervention.冠状动脉穿孔并发经皮冠状动脉介入治疗
Asian Cardiovasc Thorac Ann. 2018 Feb;26(2):101-106. doi: 10.1177/0218492318755182. Epub 2018 Jan 16.
6
Coronary perforation in the drug-eluting stent era: incidence, risk factors, management and outcome: the UK experience.药物洗脱支架时代的冠状动脉穿孔:发生率、危险因素、处理和结局:英国经验。
EuroIntervention. 2012 May 15;8(1):79-86. doi: 10.4244/EIJV8I1A13.
7
Outcomes of patients who undergo percutaneous coronary intervention with covered stents for coronary perforation: A systematic review and pooled analysis of data.经皮冠状动脉介入治疗中使用带膜支架治疗冠状动脉穿孔患者的结局:系统评价和汇总分析数据。
Catheter Cardiovasc Interv. 2020 Dec;96(7):1360-1366. doi: 10.1002/ccd.28646. Epub 2019 Dec 18.
8
PK Papyrus covered stent: Device description and early experience for the treatment of coronary artery perforations.PK 纸莎草涂层支架:用于治疗冠状动脉穿孔的器械描述和早期经验。
Catheter Cardiovasc Interv. 2019 Oct 1;94(4):564-568. doi: 10.1002/ccd.28306. Epub 2019 Apr 29.
9
Changing outcomes and treatment strategies for wire induced coronary perforations in the era of bivalirudin use.在比伐卢定使用时代,导丝引起的冠状动脉穿孔的转归和治疗策略的改变。
Catheter Cardiovasc Interv. 2009 Nov 1;74(5):700-7. doi: 10.1002/ccd.22112.
10
Coronary Perforation Complicating Percutaneous Coronary Intervention in Patients With a History of Coronary Artery Bypass Surgery: An Analysis of 309 Perforation Cases From the British Cardiovascular Intervention Society Database.冠状动脉穿孔并发经皮冠状动脉介入治疗患者的冠状动脉旁路手术史:英国心血管介入学会数据库中的 309 例穿孔病例分析。
Circ Cardiovasc Interv. 2017 Sep;10(9). doi: 10.1161/CIRCINTERVENTIONS.117.005581.

引用本文的文献

1
Case report: Uncontrollable coronary artery perforation caused by severe stenosis proximal to loopy vessels.病例报告:迂曲血管近端严重狭窄导致无法控制的冠状动脉穿孔。
Front Cardiovasc Med. 2025 Jul 1;12:1609557. doi: 10.3389/fcvm.2025.1609557. eCollection 2025.
2
PERCUTANEOUS CORONARY INTERVENTION OF THE SMALL DIAGONAL BRANCH IN ACUTE MYOCARDIAL INFARCTION WITHOUT ST ELEVATION COMPLICATED BY CORONARY ARTERY PERFORATION AND CARDIAC TAMPONADE.非ST段抬高型急性心肌梗死合并冠状动脉穿孔及心脏压塞时小对角支的经皮冠状动脉介入治疗
Acta Clin Croat. 2024 Mar;63(Suppl1):47-53. doi: 10.20471/acc.2024.63.s1.9.
3
Coronary recanalization following spring coil occlusion: A case report and literature review.

本文引用的文献

1
Clinical Outcomes Following Covered Stent for the Treatment of Coronary Artery Perforation.冠状动脉穿孔覆膜支架治疗后的临床结果
J Interv Cardiol. 2016 Dec;29(6):569-575. doi: 10.1111/joic.12347. Epub 2016 Oct 25.
2
Incidence, Determinants, and Outcomes of Coronary Perforation During Percutaneous Coronary Intervention in the United Kingdom Between 2006 and 2013: An Analysis of 527 121 Cases From the British Cardiovascular Intervention Society Database.2006 年至 2013 年期间英国经皮冠状动脉介入治疗中冠状动脉穿孔的发生率、决定因素和转归:英国心血管介入学会数据库中 527121 例病例分析。
Circ Cardiovasc Interv. 2016 Aug;9(8). doi: 10.1161/CIRCINTERVENTIONS.115.003449.
3
弹簧圈封堵术后冠状动脉再通:一例病例报告及文献综述
Medicine (Baltimore). 2025 Mar 14;104(11):e41929. doi: 10.1097/MD.0000000000041929.
4
The Effect of Intravascular Imaging-Guided Percutaneous Coronary Intervention on Coronary Artery Perforation.血管内成像引导下经皮冠状动脉介入治疗对冠状动脉穿孔的影响
JACC Asia. 2024 Nov 12;5(1):46-55. doi: 10.1016/j.jacasi.2024.09.004. eCollection 2025 Jan.
5
Handmade Embolization Coil for Managing Guidewire-Induced Coronary Perforation.用于处理导丝所致冠状动脉穿孔的手工栓塞线圈
JACC Case Rep. 2024 Sep 18;29(18):102528. doi: 10.1016/j.jaccas.2024.102528.
6
Electrospun bioresorbable polymer membranes for coronary artery stents.用于冠状动脉支架的电纺生物可吸收聚合物膜
Front Bioeng Biotechnol. 2024 Aug 21;12:1440181. doi: 10.3389/fbioe.2024.1440181. eCollection 2024.
7
Bail-Out Techniques in Percutaneous Intervention for Ellis Grade III Coronary Perforation in Left Main Distal Bifurcation Lesions.左主干远端分叉病变中 Ellis Ⅲ级冠状动脉穿孔经皮介入治疗中的补救技术
J Soc Cardiovasc Angiogr Interv. 2023 Mar 11;2(3):100609. doi: 10.1016/j.jscai.2023.100609. eCollection 2023 May-Jun.
8
Polycaprolactone (PCL) Film-Covered Bare Metal Stent: A Remedied Fire Extinguisher?聚己内酯(PCL)覆膜裸金属支架:一种改良的灭火器?
Korean Circ J. 2024 Aug;54(8):513-514. doi: 10.4070/kcj.2024.0187.
9
Conquer coronary artery perforation with magic hands.用妙手攻克冠状动脉穿孔。
J Geriatr Cardiol. 2024 Apr 28;21(4):379-386. doi: 10.26599/1671-5411.2024.04.002.
10
A Novel Strategy for Emergency Treatment of Coronary Perforations by Placing a Drug-Eluting Stent before Sealing off the Leakage with a Covered Stent to Improve Long-Term Outcomes in Patients with Coronary Artery Perforations.一种冠状动脉穿孔紧急治疗的新策略:先置入药物洗脱支架,再用覆膜支架封闭渗漏以改善冠状动脉穿孔患者的长期预后
J Pers Med. 2023 Oct 26;13(11):1542. doi: 10.3390/jpm13111542.
Management of guidewire-induced distal coronary perforation using autologous fat particles versus coil embolization.
使用自体脂肪颗粒与弹簧圈栓塞治疗导丝引起的冠状动脉远端穿孔
Catheter Cardiovasc Interv. 2017 Feb 1;89(2):253-258. doi: 10.1002/ccd.26542. Epub 2016 May 3.
4
Coronary Artery Perforation Following Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后冠状动脉穿孔
J Invasive Cardiol. 2016 Mar;28(3):122-31.
5
Pericardial covered stent for coronary perforations.用于冠状动脉穿孔的心包覆盖支架。
Catheter Cardiovasc Interv. 2015 Sep;86(3):400-4. doi: 10.1002/ccd.26011. Epub 2015 Jul 8.
6
Guidewire-induced coronary perforation successfully treated with subcutaneous fat embolisation: A simple technique available to all.导丝所致冠状动脉穿孔经皮下脂肪栓塞成功治疗:一种人人可用的简单技术。
Catheter Cardiovasc Interv. 2015 Dec 1;86(7):1186-8. doi: 10.1002/ccd.26003. Epub 2015 May 23.
7
Cardiac tamponade due to coronary perforation during percutaneous interventions successfully treated with microspheres.经皮介入治疗期间冠状动脉穿孔所致心脏压塞经微球成功治疗。
Clin Res Cardiol. 2014 Apr;103(4):325-7. doi: 10.1007/s00392-013-0651-5. Epub 2014 Jan 8.
8
Microsphere embolisation as an alternative for alcohol in percutaneous transluminal septal myocardial ablation.微球栓塞作为经皮腔内间隔心肌消融术治疗酒精的替代方法。
Neth Heart J. 2013 May;21(5):245-8. doi: 10.1007/s12471-013-0393-z.
9
Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies.经皮冠状动脉慢性完全闭塞介入治疗患者的血管造影成功和程序并发症:来自 65 项研究的 18061 例患者的加权荟萃分析。
JACC Cardiovasc Interv. 2013 Feb;6(2):128-36. doi: 10.1016/j.jcin.2012.10.011. Epub 2013 Jan 23.
10
Third universal definition of myocardial infarction.心肌梗死的第三次全球定义。
Eur Heart J. 2012 Oct;33(20):2551-67. doi: 10.1093/eurheartj/ehs184. Epub 2012 Aug 24.